LOTUSEYE.NSLOTUSEYE.NSNSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1.80% | +5.78% | +4.86% | +0.98% | +10.64% |
| Gross Profit Growth | +114.58% | +61.66% | +129.76% | -4.92% | -59.03% |
| EBITDA Growth | -47.41% | -69.45% | -15.40% | -26.17% | -34.81% |
| Operating Income Growth | -186.75% | +0.00% | +8.18% | +0.00% | +0.00% |
| Net Income Growth | -136.41% | +938.27% | -12.61% | +12.76% | +0.00% |
| EPS Growth | -134.38% | +925.64% | -13.33% | +20.00% | +0.00% |
| EPS Diluted Growth | -134.38% | +925.64% | -13.33% | +20.00% | +0.00% |
| Weighted Average Shares Growth | +5.92% | +4.52% | +0.84% | -6.04% | -4.32% |
| Weighted Average Shares Diluted Growth | +5.92% | +4.52% | +0.84% | -6.04% | -4.32% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +5.18% | +0.00% | -7.78% | +0.00% |
| Inventory Growth | +0.00% | +19.24% | +0.00% | -4.92% | +0.00% |
| Asset Growth | +0.00% | +4.42% | +0.00% | +2.05% | +0.00% |
| Book Value per Share Growth | -3.40% | -3.37% | +0.16% | +7.33% | +0.00% |
| Debt Growth | +0.00% | +208.92% | +0.00% | +60.53% | +0.00% |
| R&D Expense Growth | +0.00% | +8.96% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -100.00% | +16.92% | -100.00% | +0.00% | +0.00% |